Exabis Library
Welcome to the e-CCO Library!
OP013: HLA-DQA1 contributes to the development of antibodies to anti-TNF therapy in Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP013: HLA-DQA1 contributes to the development of antibodies to anti-TNF therapy in Crohn's Disease
2018
ECCO'18 Vienna
Friday, 23 March 2018, 12:23 PM
Thursday, 5 July 2018, 10:50 AM by Lindley Fritze
OP014: A multicentre, double-blind, placebo-controlled phase 3 study of ustekinumab, a human interleukins-12/23p40 mab, in moderate-severe Crohn’s disease refractory to anti-tumour necrosis factor α: UNITI-1
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP014: Analysis of 1792 gut metagenomes reveals microbial treatment targets for Inflammatory Bowel Disease and irritable bowel syndrome
2018
ECCO'18 Vienna
Friday, 23 March 2018, 12:23 PM
Thursday, 5 July 2018, 10:51 AM by Lindley Fritze
1
OP014: Analysis of 1792 gut metagenomes reveals microbial treatment targets for inflammatory bowel disease and irritable bowel syndrome
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP014: Histological remission is predictive of improved clinical outcomes in patients with Ulcerative Colitis: Results from the TOUCHSTONE OLE
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 2:49 PM by ECCO Administrator
1
OP014: Histological remission is predictive of improved clinical outcomes in patients with ulcerative colitis: results from the TOUCHSTONE open-label extension
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP015: Biomarker correlation with endoscopic outcomes in patients with Crohn’s disease: data from CALM
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP015: Biomarker correlation with endoscopic outcomes in patients with Crohn’s Disease: Data from CALM
2018
ECCO'18 Vienna
Friday, 23 March 2018, 12:23 PM
1
OP015: Cost-effectiveness of laparoscopic ileocecal resection versus infliximab treatment of terminal ileitis in Crohn's disease: the LIR!C TRIAL
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP015: Cost-effectiveness of laparoscopic ileocecal resection versus infliximab treatment of terminal ileitis in Crohn’s Disease: THE LIR!C TRIAL
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 2:47 PM by ECCO Administrator
1
OP015: Results of ANDANTE, a randomised clinical study with an anti-IL6 antibody (PF-04236921) in subjects with Crohn’s disease who are anti-tumour necrosis factor inadequate responders
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP016: Development and validation of diagnostic criteria for IBD-unclassified (IBDU) in children: a multicentre longitudinal study from the paediatric IBD Porto Group of ESPGHAN
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP016: Need for primary abdominal surgery, but not repeated surgery, has decreased – a nationwide study of temporal trends in Crohn surgery in Sweden 1990-2014
2018
ECCO'18 Vienna
Friday, 23 March 2018, 12:23 PM
1
OP016: Need for primary abdominal surgery, but not repeated surgery, has decreased: a nationwide study of temporal trends in Crohn surgery in Sweden 1990–2014
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP016: Potential role of bile acid receptor FXR in microscopic colitis
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 2:17 PM by Vesna Babaja
1
OP016: Potential role of bile acid receptor FXR in microscopic colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP017: Multi-donor intense faecal microbiota transplantation is an effective treatment for resistant ulcerative colitis: a randomised placebo-controlled trial
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP017: Telemedicine enables a safe shift from examination room based care to personalised care for Inflammatory Bowel Disease: A pragmatic randomised multicenter trial with myIBDcoach
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 2:21 PM by Vesna Babaja
1
OP017: Telemedicine enables a safe shift from examination room based care to personalised care for inflammatory bowel disease: a pragmatic randomised multicenter trial with myIBDcoach
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM